High throughput screening for new drug discovery

被引:0
|
作者
Lin, BB [1 ]
机构
[1] PANLABA TAIWAN LTD,TAIPEI 112,TAIWAN
关键词
high throughput screening (HTS); drug discovery; laboratory information management systems (LIMS); natural products discovery; secondary microbial metabolites; combinatorial chemistry; peptide combinatorial libraries; combinatorial organic synthesis;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The world pharmaceutical market, which was valued at $247.9 billion in 1994, is forecasted to grow to $342 billion by 1999. High throughput screening(HTS) is attracting attention as a novel methodology for new drug discovery, HTS is expected to expand the scale from one thousand to one hundred thousand times the current level by utilizing robots, laboratory information management systems(LIMS), various sources to screen natural products(plant extracts, secondary microbial metabolites), peptide combinatorial libraries and combinatorial organic synthesis(COS) for new therapeutics, Instrumentation, target selection, source material, sample preparation, primary and secondary assays, isolation, purification and structure elucidation are all important for HTS.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 50 条
  • [31] Hot Topic: Pharmacophore Mapping and High Throughput Screening in Drug Discovery
    Roy, Kunal
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 963 - 964
  • [32] Perfect high throughput screening assay: a crucial technique for drug discovery
    Guan-hua DU~1 Institute of Materia Medica
    Acta Pharmacologica Sinica, 2005, (10) : 1174 - 1174
  • [33] High Throughput Screening for Anti-Trypanosoma cruzi Drug Discovery
    Alonso-Padilla, Julio
    Rodriguez, Ana
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (12):
  • [34] Adaptation of High-Throughput Screening in Drug Discovery-Toxicological Screening Tests
    Szymanski, Pawel
    Markowicz, Magdalena
    Mikiciuk-Olasik, Elzbieta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (01): : 427 - 452
  • [35] High-Throughput Drug Screening of ECM Deposition Inhibitors for Antifibrotic Drug Discovery
    Gerckens, Michael
    Alsafadi, Hani
    Wagner, Darcy
    Heinzelmann, Katharina
    Schorpp, Kenji
    Hadian, Kamyar
    Lindner, Michael
    Behr, Juergen
    Koenigshoff, Melanie
    Eickelberg, Oliver
    Yildirim, Ali Oender
    Burgstaller, Gerald
    PNEUMOLOGIE, 2019, 73 (02):
  • [36] High-throughput drug screening - The new approach
    Chaumat, P
    ANALUSIS, 1996, 24 (02) : M35 - M37
  • [37] Drug discovery for male subfertility using high-throughput screening: a new approach to an unsolved problem
    da Silva, Sarah J. Martins
    Brown, Sean G.
    Sutton, Keith
    King, Louise V.
    Ruso, Halil
    Gray, David W.
    Wyatt, Paul G.
    Kelly, Mark C.
    Barratt, Christopher L. R.
    Hope, Anthony G.
    HUMAN REPRODUCTION, 2017, 32 (05) : 974 - 984
  • [38] High throughput screening for biomaterials discovery
    Algahtani, Mohammed S.
    Scurr, David J.
    Hook, Andrew L.
    Anderson, Daniel G.
    Langer, Robert S.
    Burley, Jonathan C.
    Alexander, Morgan R.
    Davies, Martyn C.
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 115 - 126
  • [39] High throughput drug screening
    Heemskerk, J
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 19 - 21
  • [40] Machine Learning Assisted Hit Prioritization for High Throughput Screening in Drug Discovery
    Boldini, Davide
    Friedrich, Lukas
    Kuhn, Daniel
    Sieber, Stephan A.
    ACS CENTRAL SCIENCE, 2024, 10 (04) : 823 - 832